StockNews.com Initiates Coverage on Calithera Biosciences (NASDAQ:CALA)

Analysts at StockNews.com began coverage on shares of Calithera Biosciences (NASDAQ:CALA) in a research note issued on Monday. The firm set a “hold” rating on the biotechnology company’s stock.

Calithera Biosciences Stock Performance

NASDAQ:CALA opened at $0.00 on Monday. The stock’s fifty day moving average is $0.02 and its 200 day moving average is $0.02. Calithera Biosciences has a fifty-two week low of $0.00 and a fifty-two week high of $0.12.

Calithera Biosciences Company Profile

Calithera Biosciences, Inc operates under a plan of liquidation that was approved in January 2023. Previously, the company was engaged in the clinical stage precision oncology biopharmaceutical business. Calithera Biosciences, Inc was incorporated in 2010 and is headquartered in South San Francisco, California.